Search

Smith & Nephew PLC

Uždarymo kaina

1,263 -1.41

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1258.5

Max

1280.5

Pagrindiniai rodikliai

By Trading Economics

Pajamos

296M

Pardavimai

3B

P/E

Sektoriaus vid.

30.104

22.135

Pelnas, tenkantis vienai akcijai

0.429

Dividendų pajamingumas

3

Pelno marža

9.895

Darbuotojai

17,000

EBITDA

723M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+18.25% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.00%

4.29%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.9B

12B

Ankstesnė atidarymo kaina

1264.41

Ankstesnė uždarymo kaina

1263

Smith & Nephew PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-13 21:34; UTC

Uždarbis

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

2025-11-13 23:45; UTC

Rinkos pokalbiai

Nikkei May Fall After Wall Street's Weakness -- Market Talk

2025-11-13 23:42; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

2025-11-13 23:41; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Dip-Buying -- Market Talk

2025-11-13 23:24; UTC

Uždarbis

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

2025-11-13 23:24; UTC

Uždarbis

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

2025-11-13 23:23; UTC

Uždarbis

JBS NV 3Q EPS 52c >JBS

2025-11-13 23:23; UTC

Uždarbis

JBS NV 3Q Sales $22.6B >JBS

2025-11-13 23:04; UTC

Rinkos pokalbiai

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

2025-11-13 22:02; UTC

Uždarbis

Nu Holdings 3Q Net $783M >NU

2025-11-13 22:01; UTC

Uždarbis

Nu Holdings 3Q Rev $4.2B >NU

2025-11-13 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

2025-11-13 21:50; UTC

Uždarbis

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

2025-11-13 21:45; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

2025-11-13 21:41; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

2025-11-13 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

2025-11-13 21:33; UTC

Rinkos pokalbiai

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

2025-11-13 21:33; UTC

Uždarbis

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

2025-11-13 21:31; UTC

Uždarbis

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

2025-11-13 21:25; UTC

Uždarbis

Figure Tech Solutions 3Q Rev $156.4M >FIGR

2025-11-13 21:25; UTC

Uždarbis

Figure Tech Solutions 3Q EPS 34c >FIGR

2025-11-13 21:23; UTC

Uždarbis

Intchains Group 3Q Rev $1.3M >ICG

2025-11-13 21:03; UTC

Uždarbis

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

2025-11-13 21:02; UTC

Uždarbis

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

2025-11-13 21:01; UTC

Uždarbis

Applied Materials 4Q Rev $6.8B >AMAT

2025-11-13 21:01; UTC

Uždarbis

Applied Materials 4Q Gross Margin 48.0% >AMAT

Smith & Nephew PLC Prognozė

Kainos tikslas

By TipRanks

18.25% į viršų

12 mėnesių prognozė

Vidutinis 1,516 GBX  18.25%

Aukščiausias 1,700 GBX

Žemiausias 1,300 GBX

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Smith & Nephew PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

5

Pirkti

3

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat